Categories
-
Recent Posts
- New York Stem Cell Foundation scientist grows bone from human embryonic stem cells
- Study identifies how skeletal muscle stem cells respond to muscle injury
- Human embryonic stem cells can be used to grow bone tissue grafts
- Stem Cell Market & Cord Blood Banking Industry Research Reports at 10% Discount – Limited Period Offer
- Scientists discover clues to muscle stem cell functions
Recommended Sites
- Actos Lawsuit
- Body Mass Index Calculator
- Broken Link Checker
- Browser Shots
- Cancer Specialist
- Caring Medical
- Cheap Pharmacy Online
- HGH
- HGH Injections
- Hormone Decline Graphs / Calculator
- Hormone Therapy
- Human Growth Hormone
- International American University
- Medical Dictionary Search
- Medical Drugs Search
- Medical Symptoms Search
- POLIMEDICAL CENTRO POLISPECIALISTICO
- Quality of Life Assessment
- Ron Paul 2012
- Ron Paul TV
- Stem Cell Therapy for Brain Injury
- Stem Cell Therapy for Cerebral Palsy
- Stem Cell Therapy for Diabetes
- Stem Cell Therapy for Spinal Cord Injury
- Stem Cell Therapy for Stroke
- Stem Cells China
- Testosterone
- Testosterone Therapy
- Weight Loss
- Windsor Medical School
Tag Archives: development
Bioeconomy Plans
The Obama administration is to unveil its National Bioeconomy Blueprint plan today, reports The New York Times. “The growth of today’s US bioeconomy is due in large part to the development of three foundational technologies: genetic engineering, DNA sequencing, and automated high-throughput manipulations of biomolecules,” the report notes, adding that “tomorrow’s bioeconomy relies on the expansion of emerging technologies such as synthetic biology (the direct engineering of microbes and plants), proteomics (the large-scale study and manipulation of proteins in an organism), and bioinformatics (computational tools for expanding the use of biological and related data), as well as new technologies as yet unimagined.” The report adds that such technologies appear to be moving toward advances in health, bioenergy, biomanufacturing, and environmental clean-up Continue reading
Posted in Genetic Engineering
Tagged and-development, development, expansion, including-some, into-commercial, obama, recognized-the, relies-on-the, report-includes
Comments Off
Research and Markets: Biotechnology, Chemical and Materials Engineering Comprises 343 Peer-reviewed Papers
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/zfmj69/biotechnology_che) has announced the addition of the “Biotechnology, Chemical and Materials Engineering” report to their offering. Series: Advanced Materials Research, Volumes 393 – 395 Selected, peer reviewed papers from the 2011 International Conference on Biotechnology, Chemical and Materials Engineering, (CBCME 2011), December 28-29, 2011, Kunming, China This book comprises 343 peer-reviewed papers on Biotechnology, Chemical and Materials Engineering, and is intended to promote the development of these subject-areas by strengthening international academic cooperation and communication, and by exchanging research ideas. Continue reading
Posted in Biotechnology
Tagged a-new-algorithm, affiliated-with, and-materials, biotechnology, book, chemical, development, latest, markets, national, research, review-, work
Comments Off
Human neural stem cells with tumor targeting ability discovered
ScienceDaily (Apr. 20, 2012) Could engineered human stem cells hold the key to cancer survival Continue reading
Posted in Stem Cells
Tagged central-nervous, data, development, distribution, ineffectiveness, mice, nanotechnology, researchers, stem-cells, therapeutic, vectors-or-gene
Comments Off
QualityStocks News – Advance Cell Technology Completes Treatment of Third Dry AMD Patient in Phase I/II Clinical Trial
Scottsdale, Arizona (PRWEB) April 21, 2012 QualityStocks would like to highlight Advanced Cell Technology, Inc., a publicly traded biotechnology company applying cellular technology in the field of regenerative medicine. ACT specializes in the development of cellular therapies for the treatment of diseases and conditions that impact tens of millions of people worldwide. Continue reading
Posted in Cell Medicine
Tagged a-daily-basis, advanced-cell, attention, clinical, development, europe, press, procedures, school, technology, therapeutic, treated-at-ucla, trials-
Comments Off
Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013
WINSTON-SALEM, N.C., April 17, 2012 /PRNewswire/ –Tengion, Inc. (NASDAQ: TNGN – News), a leader in regenerative medicine, today announced that it recently completed a successful Pre-IND meeting with the U.S Continue reading
Posted in Regenerative Medicine
Tagged augment, chicago, clinical-trial, development, europe, kidney-augment, president, trial, united, united-states, university, urinary-conduit
Comments Off
Promising anti-diabetic substance found in liquorice root
Researchers discover promising anti-diabetic substance in the amorfrutin class of natural substances It provides the raw material for liquorice candy, calms the stomach and alleviates diseases of the airways: liquorice root. Continue reading
Posted in Molecular Genetics
Tagged amorfrutins, berlin, development, liquorice-root, plant, researchers, sascha-sauer
Comments Off
EMD Serono, Inc. Founding Donor of Newly Launched MGH Multiple Sclerosis Discovery Forum
ROCKLAND, Mass.–(BUSINESS WIRE)– EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is the founding donor of the newly launched Multiple Sclerosis (MS) Discovery Forum website (http://www.msdiscovery.org), a joint project of MassGeneral Institute for Neurodegenerative Disease (MIND), nonprofit organization Accelerated Cure Project for MS and the Max Planck Institute for Molecular Genetics. Continue reading
Posted in Molecular Genetics
Tagged a-decade-long, a-free-resource, a-joint-project, ability, development, discovery-forum, global-external, highly-regarded, mind, serono, understanding
Comments Off
Bruce R. Korf, M.D., Ph.D., Elected President of ACMG Foundation for Genetic and Genomic Medicine
More Topics: Choose a Sector Accounting Firms Advertising/Media/Communications Capital CEO/Board General Business Health/Biotech Internet/Technology Investment Firms Law Firms Mergers & Acquisitions Money Managers People Private Companies Public Companies Venture Capital Posted April 17, 2012 Bruce R. Korf BETHESDA, Md. — Bruce R Continue reading
Posted in Genetic Medicine
Tagged acmg, association, children, college-, development, genetics, human-genetics, medical, president, university
Comments Off
ACT Announces Second Patient with Dry AMD Treated in U.S. Clinical Trial with RPE Cells Derived from Embryonic Stem …
MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the second patient was dosed in the Companys Phase I/II trial for dry age-related macular degeneration (dry AMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs). The patient is recovering uneventfully. Continue reading
Posted in Cell Medicine
Tagged advanced-cell, based-on-the, beliefs, development, safety, second, technology, time, united-states
Comments Off
BioTime CEO Michael D. West to Present at the 8th GTC Stem Cell Summit 2012
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. Continue reading
Posted in Cell Medicine
Tagged a-blood-plasma, chief-executive, development, diagnostic, focuses-on-the, massachusetts, stem-cell, treatment
Comments Off